Sydney Jennings

Findings suggest that optimizing care for children with hypertension may reduce the risk of adult CVD, report researchers.

Your daily dose of the clinical news you may have missed.

Patients with HF who received SGLT2i therapy had significant improvement in functional capacity and QOL, regardless of sex, diabetes status, or ejection fraction, report researchers.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

More advanced practice clinicians and fewer physicians are providing contraception services, researchers reported.

Your daily dose of the clinical news you may have missed.

Dr Nissen discusses the impetus behind the study, the potential public health implications of the results, and more.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Adults receiving semaglutide for the first time achieved weight loss of 14.3% at 12 months vs 10.6% among those who had previously taken a different antiobesity drug.

Your daily dose of the clinical news you may have missed.

Poor cardiovascular health at midlife was associated with a decline in the mental processing speed of Black women, but not White women, according to a new study.

Your daily dose of the clinical news you may have missed.

Patients with AF aged younger than 65 years have substantial comorbidity burden that may impact their future risk of mortality, reported researchers.

Your daily dose of the clinical news you may have missed.

Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.

Your daily dose of the clinical news you may have missed.

Women with new-onset HTN faced a 45% greater risk of newly self-reported fibroids and those with untreated HTN had a 19% greater risk, according to a new study.

Your daily dose of the clinical news you may have missed.

Vaccine efficacy remained high at 82% at year 11 following vaccination, according to new long-term data.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

With the rise in demand for newer antiobesity medications, clinicians may face more questions from patients. Here, a primer on the drawbacks and benefits to keep in mind.

Nearly one-quarter of hospitalized adults aged 50 years and older with RSV experienced an acute cardiac event, according to results of a new study.

Your daily dose of the clinical news you may have missed.

Results of a recent study support the importance of lifestyle interventions to reduce the burden of breathlessness in middle-aged adults.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

The additional indication for benralizumab was supported by data from the phase 3 TATE trial.